Zoetis | ZTS - Ebitda

Stock Price
122.41
Daily Change
-2.53 -2.03%
Monthly
-5.38%
Yearly
-28.93%
Q1 Forecast
120.98

Zoetis reported $1.04B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
Align Technology USD 203.61M 66M Jun/2025
Bayer EUR 1.51B 1.28B Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Dentsply International USD 167M 30M Sep/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Henry Schein USD 295M 39M Sep/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
J&J USD 9.52B 389M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Neogen USD 48.75M 13.28M Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Quest Diagnostics USD 561M 9M Sep/2025
Sanofi EUR 4.84B 2.95B Sep/2025
Sanofi EUR 5.66B 3.77B Sep/2025
Zoetis USD 1.04B 87M Sep/2025